Related Experiment Video
Updated: May 8, 2026

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Correlation between genotype and phenotype in patients with bi-allelic SLC26A4 mutations
Clinical Genetics
|September 7, 2013
Summary
Mutations in SLC26A4 are a common cause of hearing loss in East Asia. Specific genotypes correlate with the degree of residual hearing, offering insights into inner ear phenotypes.
Area of Science:
- Genetics
- Otolaryngology
- Molecular Biology
Background:
- SLC26A4 gene mutations are the primary cause of prelingual hearing loss in East Asia.
- Phenotypes associated with SLC26A4 mutations vary, including non-syndromic hearing loss and Pendred syndrome.
Purpose of the Study:
- To investigate the correlation between SLC26A4 genotype and inner ear phenotypes in patients with enlarged vestibular aqueduct (EVA).
- To elucidate the underlying molecular mechanisms linking genotype to hearing loss severity.
Main Methods:
- Analysis of 111 patients with bi-allelic SLC26A4 mutations and bilateral EVA.
- Genotyping to identify common mutations (p.H723R, c.919-2A>G, p.T410M).
- Quantitative PCR and cell-based assays to assess pendrin transcript levels, surface expression, and anion exchange activity.
Main Results:
- p.H723R, c.919-2A>G, and p.T410M were the most frequent mutations in Korean EVA patients.
- Patients with c.919-2A>G or p.T410M mutations exhibited better residual hearing than those with homozygous p.H723R mutations.
- Normal pendrin transcript levels were observed in patients with homozygous c.919-2A>G mutations, with higher surface expression and anion exchange activity for p.T410M compared to p.H723R.
Conclusions:
- A significant correlation exists between SLC26A4 genotype and the degree of residual hearing in East Asian populations.
- Genotype influences the functional expression of pendrin, impacting inner ear phenotypes.
- Understanding these genotype-phenotype correlations can aid in predicting hearing loss progression and potential therapeutic strategies.
More Related Videos
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Genetic Lingo
Overview
Multiple Allele Traits
The Concept of Multiple Allelism
Pedigree Analysis
Overview
Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

